Wealth Management Associates, Inc. Gilead Sciences, Inc. Transaction History

Wealth Management Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 May 28, 2025	SELL	$67.69 - $73.03 $230,078 - $248,228	-3,399 Closed	0 $0
Q2 2021 May 28, 2025	SELL	$63.47 - $69.35 $39,986 - $43,690	-630 Reduced 15.64%	3,399 $234 Million
Q1 2021 May 28, 2025	SELL	$60.0 - $68.46 $13,200 - $15,061	-220 Reduced 5.18%	4,029 $260 Million
Q4 2020 May 28, 2025	SELL	$56.65 - $64.55 $10,197 - $11,619	-180 Reduced 4.06%	4,249 $248 Million
Q3 2020 May 28, 2025	SELL	$62.1 - $78.08 $346,269 - $435,374	-5,576 Reduced 55.73%	4,429 $280 Million
Q2 2020 May 28, 2025	BUY	$72.34 - $84.0 $108,075 - $125,496	1,494 Added 17.55%	10,005 $770 Million
Q1 2020 May 28, 2025	BUY	$62.63 - $80.22 $533,043 - $682,752	8,511 New	8,511 $636 Million

2,286

997M

9.62M

10M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $137B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Wealth Management Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Wealth Management Associates, Inc. with notifications on news.